Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 367

1.

The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome.

Albert C, Garrido N, Mercader A, Rao CV, Remohí J, Simón C, Pellicer A.

Mol Hum Reprod. 2002 May;8(5):409-18.

2.

The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.

Rizk B, Aboulghar M, Smitz J, Ron-El R.

Hum Reprod Update. 1997 May-Jun;3(3):255-66. Review.

3.
4.

Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.

Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG.

Oncogene. 1997 Nov 27;15(22):2687-98.

6.

Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast.

Shore VH, Wang TH, Wang CL, Torry RJ, Caudle MR, Torry DS.

Placenta. 1997 Nov;18(8):657-65.

PMID:
9364601
7.
8.

Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B.

Am J Pathol. 1998 Jun;152(6):1433-43.

9.

The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.

Pellicer A, Albert C, Mercader A, Bonilla-Musoles F, Remohí J, Simón C.

Fertil Steril. 1999 Mar;71(3):482-9.

PMID:
10065786
11.

Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea.

Endo T, Kitajima Y, Nishikawa A, Manase K, Shibuya M, Kudo R.

Fertil Steril. 2001 Oct;76(4):762-8.

PMID:
11591411
12.

Ovarian steroids in endometrial angiogenesis.

Perrot-Applanat M, Ancelin M, Buteau-Lozano H, Meduri G, Bausero P.

Steroids. 2000 Oct-Nov;65(10-11):599-603.

PMID:
11108865
13.

Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells.

Shen BQ, Lee DY, Cortopassi KM, Damico LA, Zioncheck TF.

J Biol Chem. 2001 Feb 16;276(7):5281-6. Epub 2000 Oct 31.

14.
15.

Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.

Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Shibuya M, Inada M, Matsubara H, Iwasaka T.

J Mol Cell Cardiol. 1999 Mar;31(3):607-17.

PMID:
10198191
17.
18.

Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.

Brekken RA, Overholser JP, Stastny VA, Waltenberger J, Minna JD, Thorpe PE.

Cancer Res. 2000 Sep 15;60(18):5117-24.

19.

17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells.

Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H, Kobayashi K, Honda Y.

Invest Ophthalmol Vis Sci. 1999 Aug;40(9):2122-9.

PMID:
10440269
20.

Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas.

Philipp W, Speicher L, Humpel C.

Invest Ophthalmol Vis Sci. 2000 Aug;41(9):2514-22.

PMID:
10937562
Items per page

Supplemental Content

Write to the Help Desk